Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prognostic Stage IIIA Breast Cancer AJCC v8”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00003269
What this trial is testing

Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors

Who this might be right for
Breast CancerDrug/Agent Toxicity by Tissue/OrganLung Cancer+3 more
Scripps Health 20
Not applicableWithdrawnNCT01695057
What this trial is testing

Vorinostat Before Surgery in Treating Patients With Triple-Negative Breast Cancer

Who this might be right for
Stage II Breast CancerStage IIIA Breast CancerTriple-negative Breast Cancer
University of Southern California
Not applicableLooking for participantsNCT01000883
What this trial is testing

Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior

Who this might be right for
Breast Cancer
UNC Lineberger Comprehensive Cancer Center 10,000
Not applicableStudy completedNCT00968682
What this trial is testing

CADY Study ICORG 08-01

Who this might be right for
Breast CancerCardiac Toxicity
Cancer Trials Ireland 480
Not applicableStudy completedNCT00534274
What this trial is testing

Positron Emission Tomography Using 3'-Deoxy-3'-(18F) Fluorothymidine in Treating Women With Locally Advanced Cancer in One Breast Who Are Receiving Chemotherapy

Who this might be right for
Breast Cancer
UNICANCER 97
Not applicableStudy completedNCT03707574
What this trial is testing

Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study

Who this might be right for
Advanced Malignant NeoplasmAdvanced MelanomaAdvanced Renal Cell Carcinoma+51 more
National Cancer Institute (NCI) 64
Testing effectiveness (Phase 2)WithdrawnNCT01612910
What this trial is testing

Oral Microencapsulated Diindolylmethane in Treating Patients With Stage II-III Triple Negative, Androgen Receptor Positive Breast Cancer Who Have Undergone Chemotherapy and Surgery

Who this might be right for
Breast Cancer Female
Barbara Ann Karmanos Cancer Institute
Testing effectiveness (Phase 2)Ended earlyNCT02269670
What this trial is testing

Phase II Study of Everolimus Beyond Progression

Who this might be right for
Estrogen Receptor-positive Breast CancerHER2-negative Breast CancerProgesterone Receptor-positive Breast Cancer+5 more
Emory University 3
Not applicableStudy completedNCT04454086
What this trial is testing

Exercise and Diet Counseling Program in Improving Quality of Life in Stage I-III Breast Cancer Survivors

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+20 more
Ohio State University Comprehensive Cancer Center 21
Not applicableStudy completedNCT01478477
What this trial is testing

Omega-3 Fatty Acids in Preventing Joint Symptoms in Patients With Stage I-III Breast Cancer Receiving Anastrozole, Exemestane, or Letrozole

Who this might be right for
Recurrent Breast CancerStage IA Breast CancerStage IB Breast Cancer+4 more
Ohio State University Comprehensive Cancer Center 44
Testing effectiveness (Phase 2)Looking for participantsNCT05269381
What this trial is testing

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more
Mayo Clinic 138
Testing effectiveness (Phase 2)Ended earlyNCT00499681
What this trial is testing

PhII Neo-Adjuvant Letrozole & Lapatinib in Pts w/HER2+ & Hormone Receptor+ Operable Breast CA SPORE

Who this might be right for
Breast Cancer
Vanderbilt-Ingram Cancer Center 6
Large-scale testing (Phase 3)UnknownNCT01031030
What this trial is testing

Cyclophosphamide, Methotrexate, and Fluorouracil, With or Without Epirubicin Hydrochloride, in Treating Women Who Have Undergone Surgery for Breast Cancer (Group III Closed to New Patients as of 12/7/2009)

Who this might be right for
Breast Cancer
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 800
Testing effectiveness (Phase 2)Study completedNCT00044993
What this trial is testing

Chemotherapy Combined With Gene Therapy in Treating Patients Who Have Stage III or Stage IV Breast Cancer

Who this might be right for
Breast Cancer
Introgen Therapeutics
Early research (Phase 1)Ended earlyNCT01051401
What this trial is testing

Rosuvastatin in Treating Women With Cardiovascular Complications Who Are Undergoing Chemotherapy For Breast Cancer

Who this might be right for
Cardiovascular ComplicationsRecurrent Breast CancerStage I Breast Cancer+5 more
Wake Forest University Health Sciences 5
Very early researchStudy completedNCT02646319
What this trial is testing

Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations

Who this might be right for
Advanced Malignant NeoplasmCervical Squamous Cell CarcinomaEndometrial Carcinoma+29 more
Mayo Clinic 2
Not applicableStudy completedNCT00681928
What this trial is testing

Cognitive Function in Older Women With Stage I, Stage II, or Stage III Breast Cancer Receiving Hormone Therapy

Who this might be right for
Breast Cancer
City of Hope Medical Center 72
Very early researchStudy completedNCT00949247
What this trial is testing

Docetaxel,Carboplatin,Trastuzumab and Bevacizumab for Breast Cancer and Bone Marrow Micrometastases

Who this might be right for
Breast Cancer
Case Comprehensive Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT00066378
What this trial is testing

Anastrozole With or Without Gefitinib in Treating Postmenopausal Women With Metastatic or Locally Recurrent Breast Cancer

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 71
Large-scale testing (Phase 3)Study completedNCT00630032
What this trial is testing

Safety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast Cancer

Who this might be right for
Breast Cancer
UNICANCER 762
Next Page